Clinical Trial Update: RI-001 in Immunosuppressed Respiratory Syncytial Virus (RSV) Infected Patients at Risk of Lower Tract RSV Illness [Phase 2]

View source ↗

Summary

A Phase 2 study update reports the results of RI-001 in immunosuppressed patients infected with Respiratory Syncytial Virus at risk for lower respiratory tract …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lower Respiratory Tract Infection
• Respiratory Syncytial Virus Infection

Drugs mentioned

• RI-001

Snippet

Sponsor: ADMA Biologics, Inc. | Conditions: Upper Respiratory Tract Infection, Lower Respiratory Tract Infection | Phase 2 | Status: COMPLETED | Results posted: 2013-04-24